Management of Severe Asthma in Eosinophilic Granulomatosis with Polyangiitis with Interleukin-5-Targeted Therapies: Current Status and Report of Two Cases

Management of Severe Asthma in Eosinophilic Granulomatosis with Polyangiitis with Interleukin-5-Targeted Therapies: Current Status and Report of Two Cases

Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic disorder characterized by peripheral eosinophilia, severe eosinophilic asthma, sinusitis, transient pulmonary infiltrates, and features of medium/small-vessel vasculitis. EGPA belongs to the group of anti-neutrophil cytoplasm antibod...

Full description

Bibliographic Details
Main Authors: Ciro Romano, Domenico Cozzolino, Ausilia Sellitto, Luca Rinaldi
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Applied Sciences
Subjects:
eosinophilic granulomatosis with polyangiitis
EGPA
Churg–Strauss syndrome
mepolizumab
benralizumab
interleukin-5
Online Access:https://www.mdpi.com/2076-3417/12/22/11535

Internet

https://www.mdpi.com/2076-3417/12/22/11535

Similar Items